Home / Biotechnology / Anatomic P

Anatomic Pathology Market By Product (Instruments, Consumables, Services), By Application (Disease Diagnosis, Drug Discovery And Development) - Growth, Future Prospects, And Competitive Analysis, 2017 -2025

This report on global anatomic pathologymarket studies various products and application prevalent in the market.According to the Centers for Disease Control and Prevention the budget for chronic disease prevention and health promotion for the financial year 2017 is US$1.1 Bn which is self-explanatory regarding the involvement of health regulatory authorities’ drive to promote health and awareness throughout the globe.The drivers of the anatomic pathology market are rising prevalence of critical illness, increasing inclination for a healthier lifestyle, rising demand for personalized medication and supportive reimbursement scenario.

For the purpose of this study, various productsof anatomic pathologystudied include instruments, consumables and services.The instruments segment is further categorized into tissue processing systems, slides staining system, microtomes and others; the consumables are sub-segmented as reagent and kits, antibodies and probes, whereas the services include cytopathology, histopathology and others. The application segment comprises of disease diagnosis, drug discovery and development, and others.Market size estimates and forecast for these segments for the period 2015 to 2025 are provided in terms of US$ Mn along with the respective CAGRs for the period 2017 to 2025, considering 2016 as the base year.

The geographic segmentation of the global anatomic pathology market is performed for the regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa markets.To further elucidate, the major geographical market are segmented into country specific market as follows:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • AsiaPacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Mexico
    • Brazil
    • Rest of LATAM
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

The regions are also further sub-segmented on the basis of, cross-sectional study by product, application and major countries. Market size estimates and forecast for these segments for the period 2015 to 2025are provided in terms of US$ Mn along with the respective CAGRs for the period 2017 to 2025, considering 2016as the base year.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global anatomic pathologymarket. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the global anatomic pathologymarket. The key players profiled in this report are Abbott Laboratories, Inc., Agilent Technologies, Inc., Boston Scientific Corporation, Danaher Corporation, F.Hoffman La Roche AG, Laboratory Corporation of America Holdings, Neogenomics Laboratories, Inc., Quest Diagnostics Incorporated, Sakura Finetechnical Co. Ltd., and Thermo Fisher Scientific, Inc.

Anatomic Pathology Market

Based on application areas, the global anatomic pathology market is categorized into

  • Disease Diagnosis
  • Drug Discovery and Development
  • Others

Anatomic Pathology Market

Anatomic pathology finds huge application scope because of its utility that helps patient to survive critical disease through knowledge input from sophisticated tools like pharmacogenomics and new genome sequencing etc.Rise in government grants to grow R&D for biomedical applications, growth in patient pool and technological advancement in the devices utilized for diagnostics has fuelled the anatomic pathology application market. Lack of skilled labor and risk of inaccurate interpretation are the restraints for the anatomic pathology market.  In 2016, disease diagnosisheld the largest market share among all the application areas due to rise in chronic diseases and cancer, aging population and increasing inclination for a healthier lifestyle. Drug discovery and development will be the fastest growing segment throughout the forecast period 2017-2025, due to factors such as enhanced expenditure by government and non-government organizations in R&D initiatives for introduction of novel and further efficacious drugs, rising demand for personalized medication and merger and acquisitionsin the healthcare industry to fortify their product portfolio.

Based on products, the global anatomic pathology market is categorized into

  • Instruments
    • Tissue processing systems
    • Slides staining systems
    • Microtomes
    • Others
  • Consumables
    • Reagents and kits
    • Antibodies
    • Probes
  • Services
    • Cytopathology
    • Histopathology
    • Others

Anatomic Pathology Market

The anatomic pathology market is driven by factors such as rising prevalence of chronic diseases, aging population, increasing demand for superior medical care, and mergers and acquisitionsamong healthcare and insurance companies. In 2016 services segment held the largest revenue share in the market chiefly due to factors such as rising prevalence of critical illness requiring immediate medical attention.According to the World Health Report 2002, chronic diseases will account for 73% of all deaths and 60% of the global disease burden by 2020; aging population and technological advancement in the diagnostic techniques will thus propel the services market. Instruments will be the fastest growing market throughout the forecast period 2017-2025 due to drivers such as technological advancement in design and software, emergence of higher resolution real time imaging of diagnosis and highly reliable and accurate interpretation of the diagnosis performed. The major players in providing the products and services of anatomic pathology market are Agilent Technologies, Thermo Fisher Scientific, Inc., Sakura Finetechnical Co. Ltd., F.Hoffman La Roche AG and NeoGenomics Laboratories, Inc.

Choose License Type
Published Date:  Jul 2017
Category:  Biotechnology
Report ID:   58559
Report Format:   PDF
Pages:   120
Rating:    4.2 (40)
Connect With Us
+1-408-641-3282
24/7 Research Support